Top Markets
Coin of the day
Bora Pharmaceuticals Co., Ltd. Bora Pharmaceuticals Co., Ltd.

Bora Pharmaceuticals Co., Ltd.

6472
주식 순위 #6969
Globally, Bora Pharmaceuticals Co., LTD. is engaged in the comprehensive... Globally, Bora Pharmaceuticals Co., LTD. is engaged in the comprehensive lifecycle of pharmaceutical products, encompassing research and development, manufacturing, distribution, and sales. The organization operates through key divisions, including Sales, Contract Development & Manufacturing Organization (CDMO), and other ancillary services. Bora produces and markets a diverse range of medicines, from generic and proprietary brand-name drugs to over-the-counter (OTC) remedies. Beyond its in-house portfolio, the company provides extensive contract development and manufacturing solutions. These CDMO services cover all stages of pharmaceutical development, clinical and commercial production, specialized packaging and serialization, rigorous analytical and microbiological quality control, and expert guidance on regulatory compliance. Furthermore, Bora's offerings extend to nutritional supplements, skincare products, and various biotechnical services. The company distributes its goods directly to healthcare facilities such as clinics, pharmacies, and pharmacy chains, as well as to drugstores. It also leverages distributors to supply larger institutions like medical centers, corporate and public hospitals, and regional and district hospitals. Established in 2007, Bora Pharmaceuticals Co., LTD. is based in Taipei City, Taiwan.
주가
$13.96
시가총액
$1.78B
변동 (1일)
-0.11%
변동 (1년)
-41.91%
국가
TW
거래 Bora Pharmaceuticals Co., Ltd. (6472)

카테고리

Bora Pharmaceuticals Co., Ltd. (6472)의 EPS
2026 기준 EPS TTM: 0
Bora Pharmaceuticals Co., Ltd.의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 0입니다. 2026년 말에는 회사의 EPS가 0였으며, 이는 2026년의 EPS 0와 동일입니다.
Bora Pharmaceuticals Co., Ltd.의 EPS 기록 (2026 ~ 2026)
매년 말의 EPS
연도 EPS 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.